Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cebranopadol for painful diabetic peripheral neuropathy
2013-000473-68Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cebranopadol in diabetic polyneuropathy (DPN) (4 arms), sponsored by Grünenthal GmbH. Started Jun 2013; status: completed.
02
Drugs
cebranopadol
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2013-000473-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000473-68.